1 Preface
1.1 Table of Contents
1.2 Abbreviations
1.3 Related Reports
1.4 Upcoming Related Reports

2 Executive Summary
2.1 Key Findings
2.2 Key Events

3 Introduction
3.1 Report Scope
3.2 Disease Overview Epidemiology Overview
3.3 Epidemiology

4 Marketed Drugs Assessment
4.1 Marketed Drugs Overview
4.2 Marketed Drug Profiles

5 Pipeline Assessment
5.1 Pipeline Overview
5.2 Pipeline Breakdown by Region
5.3 Pipeline Breakdown by Molecule Type and Target
5.4 Drug Review Designations
5.5 Phase Transition Success Rates
5.6 Likelihood of Approval

6 Clinical Trial Assessment
6.1 Clinical Trials Overview by Phase
6.2 Overview by Region
6.4 Therapy Area Perspective
6.4 Leading Sponsors
6.5 Enrollment Analytics
6.6 Feasibility Analysis

7 Commercial Assessment
7.1 Upcoming Market Catalysts

8 Social Media and Digital Marketing
8.1 Key Twitter Chatter
8.2 Top Branded Websites
8.3 Trust Flow and Citation Flow

9 Appendix
9.1 Methodology
9.2 About the Authors
9.3 About GlobalData
9.4 Contact Us
9.5 Disclaimer